Apexigen, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 32.07 million compared to USD 28.92 million a year ago. Basic loss per share from continuing operations was USD 1.62 compared to USD 1.6 a year ago.
1st Jan change | Capi. | |
---|---|---|
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |